fda warns semaglutide The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications Semaglutide: FDA publishes warning amid

Pricing Breakdown Sheds compounded semaglutide injections start at $199/month, which may increase to $299/month at higher doses

Take Care of Your Mental Health and Well-Being Stress is another factor that can spike your appetite and cause food cravings

It has been estimated that 12% of the US population has had exposure to a GLP-1RA and 6% are currently using one 11

If a skin condition develops at a preferred injection site, rotate to an unaffected area and allow the condition to resolve completely before returning

And, a 2023 report from the legislature's Joint Commission on Healthcare found 68% percent of Virginia's adults are overweight or obese